Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety (Q74333038)
Jump to navigation
Jump to search
scientific article published on 01 July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety |
scientific article published on 01 July 2002 |
Statements
Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety (English)